S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ABEO Abeona Therapeutics Inc

6.05

0.07 (1.17%)

Last Updated: 04:57:08

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Abeona Therapeutics Charts.

Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Abeona Therapeutics Charts.

Abeona Therapeutics Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Thursday 14 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
Tuesday 12 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Abeona Therapeutics® Announces Participation in November Investor Conferences
Monday 4 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 29 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
Tuesday 29 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 18 October 2024 (1 month ago) • Edgar (US Regulatory)

More Abeona Therapeutics Inc News Articles

FER HERINGER ON

INAV XTR2 ESG GLAGGSF

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions